Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Tolerability of Yaq-001 in Patients With Cirrhosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03202498
Recruitment Status : Terminated (COVID-19 pandemic prevents patients from making in-hospital visits, which are mandatory to assessment of safety in this study)
First Posted : June 28, 2017
Last Update Posted : August 25, 2020
Sponsor:
Collaborators:
University College, London
University of Brighton
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Azienda Ospedaliera di Padova
Hospital Universitari Vall d'Hebron Research Institute
IRCCS Azienda Ospedaliero-Universitaria di Bologna
University of Lisbon
Servicio Madrileño de Salud, Madrid, Spain
University of Bern
Assistance Publique - Hôpitaux de Paris
A2F Associates Limited
Alpha Bioresearch S.L.
Information provided by (Responsible Party):
Yaqrit Ltd

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : March 26, 2020
Actual Study Completion Date : March 26, 2020